Stem cell treatment for frailty in older adults
This trial tests a stem cell treatment called HeXell-2020 to see if it is safe and tolerable for older adults with mild to moderate frailty. The goal is to find ways to improve energy, strength, and overall well-being in aging adults.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 60 and 85 years old.
- You should have mild to moderate frailty, which means feeling weaker or less active than usual.
- Your weight should be between 88 and 198 pounds (about 40 to 90 kg).
- You must not be starting any new treatments for frailty during the study.
- You cannot have serious health problems like severe heart failure, advanced liver disease, or kidney failure that requires dialysis.
- You cannot have had cancer (other than easily treated skin cancer) in the last 5 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a program that looks at your physical, mental, and social well-being to help improve frailty. It involves training and using your smartphone to stay connected with peers and an instructor.
This trial tests a new stem cell treatment given through an IV to see if it is safe and well-tolerated in older adults with mild to moderate frailty. It may help improve strength and energy levels.
This study tests a new stem cell medicine given through an IV to see if it is safe for older adults with mild to moderate frailty. Frailty causes weakness and tiredness, and this treatment aims to improve overall health and function.
This study tests a treatment made from stem cells to see if it can improve strength and energy in people with frailty. It may help older adults who feel weak or tired have a better quality of life.
This study tests an investigational treatment made from special cells (called mesenchymal stromal cells) that might help reduce frailty in older adults. The treatment is given through an IV and aims to improve strength and overall function.
This early study (Phase 1) tests whether a lab-made stem cell product given through an IV is safe in people with “aging frailty.” It looks mainly at side effects and safety while also exploring whether the treatment can be given safely.
Hear when a new Frailty in Older Adults trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.